For decades men’s sexual dysfunction has been prioritized over women’s. It wasn’t until August 2015 that the FDA approved a first medical treatment option for women's most common sexual dysfunction, Hypoactive Sexual Desire Disorder. While that is a tremendous step in the right direction, the score is hardly even.
With 26 FDA-approved treatment options for men’s sexual dysfunction and only 1 for women, we have a long way to go in recognizing the important role sexual desire plays in a woman’s overall health. The FDA has recognized female sexual dysfunction as one of its 20 priority areas of unmet medical need yet women still face tremendous obstacles in accessing the first safe and effective FDA approved treatment option.
We believe, as does the World Health Organization¹, that sex is a basic human right and it is time we had equity in medical treatment options for women’s sexual health.